1. Identification, Synthesis, and Pharmacological Evaluation of Tetrahydroindazole Based Ligands as Novel Antituberculosis Agents
2. bChovatia, P. T.; Foley, A. M.; Haslett, G. W.; Hutchings, M. C.; Johnson, J. A.; Lecomte, F. C.; Monck, N. J. T.; Quincey, J. R.; Rampalakos, K.; Reuberson, J. T.; Smalley, A. P.; Trani, G.; Vaidya, D. G. Difluorocyclohexyl derivatives as IL-17 modulators. WO 2021204801 A1, 2021.
3. cConnelly, R. L.; Frost, J. R.; Gallimore, E. O.; Haslett, G. W.; Horsley, H. T.; Quincey, J. R.; Reuberson, J. T. Difluorocyclohexyl derivatives as IL-17 modulators. WO 2021170627 A1, 2021.
4. dBehenna, D.; Deckhut, C.; Rovira, A.; Goldberg, S.; Kummer, D.; Keith, J.; Woods, C.; Rhorer, T.; Tanis, V.; Martin, C.; Meduna, S.; McCarver, S.; Valdes, A.; Loskot, S.; Xue, X. Imidazopyridazines as modulators of IL-17. WO 2021222404 A1, 2021.
5. eBuerli, R.; Doyle, K.; Teall, M. Novel compounds. WO 2022167819 A1, 2022.